A comparison of bacterial resistance to antimicrobials in Riyadh, Medina, and Oklahoma City.
Miller J , Ali Si , Flournoy Dj , Tharwat Jd
The Journal of the Oklahoma State Medical Association 84 ( 10) 499 -502
1
1991
Elevated serum HER-2/neu Oncoprotein levels predict decreased response to hormone therapy in women with metastatic breast cancer
W. P. Carney , L. M. Demers , P. J. Hamer , A. Lipton
Clinical Chemistry 48(6 Supplement) 16
2002
Use of elevated bone turnover to predict bone metastasis
A. Lipton , J. W. Chapman , L. Demers , L. E. Shepherd
Journal of Clinical Oncology 26 591 -591
4
2008
Serum EGFR/HER-2 combination predicts poor survival in metastatic breast cancer
K. Leitzel , C. Souder , S. M. Ali , L. Demers
Journal of Clinical Oncology 23 9613 -9613
2
2005
Use of pretreatment serum CA9 (carbonic anhydrase 9) to predict PFS and survival in trastuzumab-treated metastatic breast cancer
K. Leitzel , H. Y. Hou , V. Shrivastava , U. Anyanwu
Journal of Clinical Oncology 27 11092 -11092
1
2009
Pretreatment serum TIMP-1 levels and survival in advanced pancreatic cancer
R. Vargas , V. Shrivastava , K. Leitzel , S. M. Ali
Journal of Clinical Oncology 27
2009
Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy
M. N. Vo , M. Evans , K. Leitzel , S. M. Ali
Breast Cancer Research and Treatment 119 ( 3) 767 -771
15
2010
GE-04COMPREHENSIVE GENOMIC PROFILING (CGP) OF PEDIATRIC GLIOMAS REVEALS A HIGH FREQUENCY OF CLINICALLY RELEVANT GENOMIC ALTERATIONS (CRGA) ASSOCIATED WITH BENEFIT FROM TARGETED THERAPY
Z. R. Chalmers , S. M. Ali , G. M. Frampton , J. Chmielecki
Neuro-oncology 17
2015
Pretreatment serum uPA and survival in patients with advanced pancreatic cancer
S. M. Ali , J. H. Marx , K. Leitzel , W. Carney
Journal of Clinical Oncology 22 4247 -4247
2
2004
Circulating tumor cells in adjuvant breast cancer patients
S. Almokadem , K. Leitzel , H. A. Harvey , E. Bannon
Journal of Clinical Oncology 23 667 -667
7
2005
Serum HER-2/neu change predicts clinical outcome to trastuzumab-based therapy
S. M. Ali , F. J. Esteva , M. Fornier , J. Gligorov
Journal of Clinical Oncology 24 500 -500
16
2006
Elevated serum M-CSF level predicts reduced survival in metastatic breast cancer patients
K. Leitzel , S. Ettenberg , R. Walsh , J. Abraham
Journal of Clinical Oncology 25 10591 -10591
4
2007
Use of total HER2 and HER2 homodimer levels to predict response to trastuzumab
K. Leitzel , A. Lipton , W. Koestler , E. Fuchs
Journal of Clinical Oncology 26 1002 -1002
7
2008
Markers of bone turnover (ICTP, NTX) and serum matrix metalloproteinase 1 (MMP1) as prognostic markers in breast cancer patients (BC) with bone metastases (BM) treated with bisphosphonates (BP)
L. A. Costa , I. Alho , S. Casimiro , A. G. Oliveira
Journal of Clinical Oncology 26 1024 -1024
6
2008
Genome-scale RNAi on living-cell microarrays identifies novel regulators of Drosophila melanogaster TORC1–S6K pathway signaling
R. A. Lindquist , K. A. Ottina , D. B. Wheeler , P. P. Hsu
Genome Research 21 ( 3) 433 -446
37
2011
Elevation in Multiple Serum Inflammatory Biomarkers Predicts Survival of Pancreatic Cancer Patients with Inoperable Disease
A. Alkhateeb , L. Zubritsky , B. Kinsman , K. Leitzel
Journal of Gastrointestinal Cancer 45 ( 2) 161 -167
10
2014
Mutations of the catalytic domain of PI3 kinase and correlation with clinical outcome in trastuzumab-treated metastatic breast cancer (MBC).
J. W. Cook , E. Paxinos , L. J. Goodman , S. M. Ali
Journal of Clinical Oncology 29 582 -582
6
2011
76P Invasive lobular breast cancer, a 14 years experience at single cancer hospital from Pakistan.
S. Ali
Annals of Oncology 27
2016
0017: A Gog Phase III Trial to Evaluate Maintaining Hemoglobin (HGB) ≥120G/L with Erythropoietin (EPO) During Chemoradiation (Ct/Rt) for Cervical Cancer
S. Ali , O. Abulafia , G. M. Thomas , M. Patel
International Journal of Gynecologic Cancer 16
2006
Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen
Harold Harvey , K. Leitzel , W. Carney , Laurence Demers
Breast Cancer Research and Treatment 69 ( 3)
5
2001
Alexa Schrock Garrett M Frampton Doron Lipson Sai-Hong Ignatius Ou Samuel Klempner, MD Zachary R Chalmers James X. Sun Roman Yelensky Sumanta Pal David M. Sabatini Shridar Ganesan Sugganth Daniel Dos Sarbassov Lee Albacker maurizio colecchia Do-Hyung Kim Alberto Briganti Christine M. Lovly, MD, PhD Andrea Gallina